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  POTENTIAL PATHOPHYSIOLOGICAL 
MECHANISMS OF ULTRAFINE PARTICLE 
TOXIC EFFECTS IN HUMANS 
Epidemiological and clinical studies suggested the association of the particu-
late matter ambient air pollution and the increased morbidity and mortality, 
mainly from respiratory and cardiovascular diseases. The size of particles has 
great influence on their toxicity, because it determines the site in the respira-
tory tract where they deposit. The most well established theory explaining the 
mechanisms behind the increased toxicity of ultrafine particles (UFP, < 0.1 µm) 
is that it has to do with the increased surface area and/or the combination with 
the increased number of particles. Biological effects of UFP are also determi-
ned by their shape and chemical composition, so it is not possible to estimate 
their toxicity in a general way. General hypothesis suggested that exposure to 
inhaled particles induces pulmonary alveolar inflammation as a basic patho-
physiological event, triggering release of various proinflammatory cytokines. 
Chronic inflammation is a very important underlying mechanism in the genesis 
of atherosclerosis and cardiovascular diseases. UFP can freely move through 
the circulation, but their effects on the secondary organs are not known yet, so 
more studies on recognizing toxicological endpoints of UFP are needed. Deter-
mination of UFP toxicity and the estimation of their internal and biologically 
active dose are necessary for the evidence based conclusions connecting air 
pollution by UFP and human diseases. 
Key words: ultrafine particles, human health, pathophysiological mecha-
nisms, chronic inflammation, respiratory disease, cardiovascular disease.
 
 
Over the last decade, numerous epidemiological 
and clinical studies have suggested the association 
between the ambient air pollution and the increased 
morbidity and mortality, mainly from respiratory and 
cardiovascular diseases [1-6]. Some air pollutants, 
like carbon monoxide, sulfur dioxide, nitrogen oxides, 
ozone, lead, and persistent organic pollutants, are 
well known toxic agents, but there is a growing in-
terest in the particulate matter (PM) deleterious ef-
fects. A particulate matter is a generic term for the 
type of air pollutants consisting of a complex and va-
rying mixture of particles suspended in the breathing 
air, which vary in size and composition and are produ-
ced by a wide variety of natural and anthropogenic 
activities [7]. Major sources of the particulate matter 
air pollution are factories, power plants, motor vehi-
cles, fires and construction activities. The size of par-
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ticles varies and according to the aerodynamic diame-
ter of a particle different categories have been defi-
ned. The coarse particle size ranges from 2.5 to 10 µm, 
and the fine particle size is 0.1-2.5 µm. Ultrafine parti-
cles (UFP) are those with diameters smaller than 0.1 µm 
[8]. This categorization has a great importance from 
the medical point of view. Beside the chemical struc-
ture and their number concentration in the air, the 
size of a particle has great influence on their toxicity. 
The size of the particles determines the site in the 
respiratory tract that they deposit. Coarse particles 
mainly stay at upper respiratory airways, while smaller 
particles reach lower, to terminal airways and alveoli. 
The strongest connections are seen for the respiratory 
and cardiac disorders. The aim of this paper is to review 
the possible pathophysiological mechanisms by which 
the ultrafine particles may affect the human health. 
ROUTES OF EXPOSURE 
Polluted air and water are the sources of pos-
sible toxic ultrafine particles, so the main routes of the 
general population exposure to ultrafine particles are 
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inhalation and ingestion, while dermal absorption is 
insignificant. There are studies indicating that in some 
cases the air pollution contributes to a great extent to 
the contamination of food and water, making inges-
tion the main route of the exposure [9]. Because of 
their small size UFP are able to reach general circu-
lation and deposit into different tissues producing pos-
sible deleterious effects [10,11]. 
POSSIBLE MECHANISMS OF UFP EFFECTS 
General hypothesis proposed by Seaton et al. 
[12] suggested that the exposure to inhaled particles 
induces alveolar inflammation as a basic pathophy-
siological event. Inflammation is a complex defense 
reaction of the organism, and some characteristic cel-
lular and humoral markers of the body response could 
be used as the measure of its occurrence and inten-
sity. Thus, the exposure to inhaled particles produces 
the increase in the blood concentration of C-reactive 
protein (CRP), fibrinogen, and proinflammatory cyto-
kines, like IL-6 and IL-1 beta. UFP cause more in-
flammation when inhaled and deposited in the lung 
than larger particles of the same material. They pos-
sess more ability to produce reactive oxygen species 
[13]. In vitro studies have also shown that UFP can 
stimulate the expression of proinflammatory genes in 
epithelial cells and alveolar macrophages. It is pro-
bably caused by their ability to increase intracellular 
calcium levels and, in this way, to inhibit phagocytosis 
[14]. There are theories trying to explain the mecha-
nisms behind the increased toxicity of ultrafine parti-
cles. The most well established theory is that it has to 
do with the increased surface area and/or combi-
nation with the increased number of particles [15,16]. 
However, biological effects of UFP are also deter-
mined by their shape and chemical composition, so it 
is not possible to estimate their toxicity in a general 
way. Some low toxic UFP may absorb substances 
with higher toxicity, like metals and gases, or may fa-
cilitate a transition of adenoviral infection. On the 
other hand, the inhibition of phagocytosis may be 
connected with the increased susceptibility to bigger 
particles or to a bacterial infection. The air pollution 
research on coarse particles, especially in occupa-
tional medicine, has established clear links between 
the increase of the particular matter in the air and lung 
diseases. The increase in a particle concentration in 
the air may overload the lung and the phagocytes that 
are responsible for the elimination of those particles. 
This overloading of the lungs causes inflammation of 
the surrounding tissue, also known as oxidative stress. 
In case of chronic exposure to UFP, persistence of a 
high inflammatory response may damage the lung tis-
sue with a clinical consequence manifested as the 
exacerbation of preexisting lung disease and/or the 
development of asthma, chronic bronchitis, lung fibro-
sis or cancer [17,18]. The degree to which UFP con-
tribute to these diseases has not been established yet. 
Inhaled UFP are also able to translocate trough 
the circulation from the point of intake into the lung to 
the secondary organs [19], and there is a possibility of 
many different interactions with biological systems of 
the body. If the size of the foreign substances ente-
ring the bloodstream is great enough, they are remo-
ved by phagocytes, but being smaller than particles 
phagocytes could recognize, UFP can freely move 
through the circulation. They can pass the blood-brain 
barrier entering the central nervous system [20], as 
well as other organs. The effects ultrafine particles 
cause in the secondary organs are not known yet. 
However, there are some evidences of their direct 
toxic effect. When instilled into the cardiac vascu-
lature, UFP produce worsening of the cardiac function 
by decreasing the cardiac coronary flow and con-
tractility [21]. So, there is a possibility that except for 
starting the pathophysiological events in the lungs, 
UFP could reach other organs through the circulation 
and produce direct effects there. 
The linkage between the airway inflammation 
with the cytokine/chemokine release and an autono-
mic stress response caused by inhalation of UFP and 
cardiovascular disorders has not been directly de-
monstrated in humans. Some links between the pul-
monary and cardiovascular response to UFP are sug-
gested. There is growing evidence from animal mo-
dels that the airway inflammatory reaction may trigger 
a systemic inflammation and hypercoagulability [22]. 
The effect of inflammation, with the increased ROS, 
proinflammatory cytokines, CRP and fibrinogen in the 
bloodstream is one of the proposed pathophysio-
logical mechanisms of UFP deleterious effects on the 
cardiovascular system [12]. Subsequently, a cascade 
of physiological responses may follow, including dis-
turbances in the blood rheology facilitating thrombosis 
and the development of atherosclerotic plaques. The 
increase in the blood coagulability is connected with a 
higher risk of cardiovascular disorders. Chronic in-
flammation is very important underlying mechanism in 
the genesis of atherosclerosis. Atherosclerosis is cha-
racterized by the formation of plaques within blood 
vessels, which may cause their narrowing or obstruct-
tion, with the consequent tissue hypoxia or necrosis. 
Clinically, it may be manifested by ECG changes of 
myocardial ischemia, like ST segment depression, or 
like more serious disorders, including angina pectoris, 
myocardial infarction, and even cardiac arrest and death. 
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The alterations in the autonomic nervous system 
induced by pulmonary reflexes may, to some extent, 
influence a vascular tonus and the cardiac impulse 
conduction, which may be manifested as fluctuations 
in the blood pressure and the heart rate including the 
occurrence of arrhythmias. The results of the studies 
investigating disturbances of a cardiac autonomic ner-
vous system are controversial [23-26] but there are 
findings supporting the notation that air pollution is 
capable of altering autonomic balance in a manner 
that favors significant tachyarrhythmias. The under-
lying responsible mechanisms remain unclear, but may 
involve the activation of pulmonary neural reflex arcs, 
a direct effect of pollutants on cardiac ion channels, or 
the consequences of the heightened systemic inflam-
matory state [27]. However, a clinical significance of 
those, comparing with other well recognized risk fac-
tors for cardiovascular diseases like age, hyperten-
sion, hyperlipidemia and diabetes is probably much lower. 
Except the non-specific proinflammatory effect 
of UFP, their ability to affect human health also de-
pends on their chemical structure. It is well recog-
nized that metals, apart from producing oxidative stress, 
can substitute diverse polyvalent proteins cations and 
impair their function. Some other substances, like di-
oxin, also may alter the metabolism by inducing a num-
ber of important metabolic enzymes [28] or act at the 
DNA level altering the expression of certain genes [29]. 
CONCLUSION 
The current knowledge base of the risks of ultra-
fine particles to human health is primarily based on 
epidemiological studies of air pollution indicating the 
increased morbidity and mortality mainly from respi-
ratory and cardiovascular diseases. Some basic bio-
logical mechanisms of UFP effects are suggested upon 
experimental studies in vitro and in vivo, on animal 
models and human volunteers, but their pathophys-
iological relevance for the development of a disease 
needs to be proved by further research. From the 
clinical toxicology point of view, more studies on re-
cognizing toxicological endpoints of UFP are needed. 
The determination of various UFP toxicity and the es-
timation of their internal and biologically active dose, 
as well as better understanding of their pathophysio-
logical pathways are necessary for the evidence based 
conclusions connecting the air pollution by UFP and 
humans diseases. 
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